Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Tiago Fauth is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/04/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.61 | 86.34% | Tiago Fauth42% | $4 → $3 | Maintains | Equal-Weight | Get Alert |
02/28/2025 | VRNA | Buy Now | Verona Pharma | $66.30 | 40.27% | Tiago Fauth42% | $74 → $93 | Maintains | Overweight | Get Alert |
02/27/2025 | KROS | Buy Now | Keros Therapeutics | $11.42 | 127.67% | Tiago Fauth42% | $28 → $26 | Maintains | Overweight | Get Alert |
02/20/2025 | FOLD | Buy Now | Amicus Therapeutics | $9.20 | 84.78% | Tiago Fauth42% | $18 → $17 | Maintains | Overweight | Get Alert |
02/19/2025 | INSM | Buy Now | Insmed | $78.94 | 35.55% | Tiago Fauth42% | $85 → $107 | Maintains | Overweight | Get Alert |
02/10/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.61 | 148.45% | Tiago Fauth42% | $41 → $4 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/31/2025 | TECX | Buy Now | Tectonic Therapeutic | $22.20 | 404.5% | Tiago Fauth42% | $79 → $112 | Maintains | Overweight | Get Alert |
01/13/2025 | INZY | Buy Now | Inozyme Pharma | $1.01 | 989.11% | Tiago Fauth42% | $14 → $11 | Maintains | Overweight | Get Alert |
01/08/2025 | VRNA | Buy Now | Verona Pharma | $66.30 | 11.61% | Tiago Fauth42% | $64 → $74 | Maintains | Overweight | Get Alert |
12/20/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.68 | 121.77% | Tiago Fauth42% | $75 → $88 | Maintains | Overweight | Get Alert |
12/20/2024 | SVRA | Buy Now | Savara | $2.98 | 168.78% | Tiago Fauth42% | → $8 | Initiates | → Overweight | Get Alert |
12/20/2024 | MNKD | Buy Now | MannKind | $5.32 | 69.17% | Tiago Fauth42% | → $9 | Initiates | → Overweight | Get Alert |
12/13/2024 | KROS | Buy Now | Keros Therapeutics | $11.42 | 145.18% | Tiago Fauth42% | $11 → $28 | Maintains | Overweight | Get Alert |
12/11/2024 | KROS | Buy Now | Keros Therapeutics | $11.42 | 871.98% | Tiago Fauth42% | $88 → $111 | Maintains | Overweight | Get Alert |
11/26/2024 | PTCT | Buy Now | PTC Therapeutics | $56.00 | 21.43% | Tiago Fauth42% | $56 → $68 | Maintains | Overweight | Get Alert |
11/12/2024 | TECX | Buy Now | Tectonic Therapeutic | $22.20 | 255.86% | Tiago Fauth42% | $55 → $79 | Maintains | Overweight | Get Alert |
11/05/2024 | VRNA | Buy Now | Verona Pharma | $66.30 | -3.47% | Tiago Fauth42% | $50 → $64 | Maintains | Overweight | Get Alert |
10/16/2024 | WVE | Buy Now | WAVE Life Sciences | $10.04 | 119.12% | Tiago Fauth42% | $11 → $22 | Maintains | Overweight | Get Alert |
10/03/2024 | VRNA | Buy Now | Verona Pharma | $66.30 | -24.59% | Tiago Fauth42% | → $50 | Initiates | → Overweight | Get Alert |
08/22/2024 | TECX | Buy Now | Tectonic Therapeutic | $22.20 | 147.75% | Tiago Fauth42% | → $55 | Initiates | → Overweight | Get Alert |
08/22/2024 | IRON | Buy Now | Disc Medicine | $53.74 | 39.56% | Tiago Fauth42% | → $75 | Initiates | → Overweight | Get Alert |
08/20/2024 | UTHR | Buy Now | United Therapeutics | $318.86 | 19.18% | Tiago Fauth42% | $350 → $380 | Maintains | Overweight | Get Alert |
08/02/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.68 | 89.01% | Tiago Fauth42% | $72 → $75 | Maintains | Overweight | Get Alert |
08/02/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $258.00 | -9.69% | Tiago Fauth42% | $207 → $233 | Maintains | Equal-Weight | Get Alert |
06/25/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $258.00 | -19.77% | Tiago Fauth42% | $161 → $207 | Maintains | Equal-Weight | Get Alert |
06/18/2024 | AVTE | Buy Now | Aerovate Therapeutics | $2.50 | -19.96% | Tiago Fauth42% | $35 → $2 | Downgrade | Overweight → Equal-Weight | Get Alert |
06/12/2024 | UTHR | Buy Now | United Therapeutics | $318.86 | 9.77% | Tiago Fauth42% | $325 → $350 | Maintains | Overweight | Get Alert |
05/30/2024 | INZY | Buy Now | Inozyme Pharma | $1.01 | 1286.14% | Tiago Fauth42% | → $14 | Initiates | → Overweight | Get Alert |
05/29/2024 | INSM | Buy Now | Insmed | $78.94 | -2.46% | Tiago Fauth42% | $55 → $77 | Maintains | Overweight | Get Alert |
05/15/2024 | WVE | Buy Now | WAVE Life Sciences | $10.04 | 9.56% | Tiago Fauth42% | → $11 | Initiates | → Overweight | Get Alert |
05/09/2024 | KROS | Buy Now | Keros Therapeutics | $11.42 | 670.58% | Tiago Fauth42% | $77 → $88 | Maintains | Overweight | Get Alert |
04/01/2024 | AVTE | Buy Now | Aerovate Therapeutics | $2.50 | 1300.62% | Tiago Fauth42% | $35 → $35 | Maintains | Overweight | Get Alert |
04/01/2024 | INSM | Buy Now | Insmed | $78.94 | -30.33% | Tiago Fauth42% | $55 → $55 | Maintains | Overweight | Get Alert |
03/07/2024 | UTHR | Buy Now | United Therapeutics | $318.86 | 1.93% | Tiago Fauth42% | $309 → $325 | Maintains | Overweight | Get Alert |
02/29/2024 | KROS | Buy Now | Keros Therapeutics | $11.42 | 574.26% | Tiago Fauth42% | $60 → $77 | Maintains | Overweight | Get Alert |
02/16/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $258.00 | -37.6% | Tiago Fauth42% | $171 → $161 | Maintains | Equal-Weight | Get Alert |
12/08/2023 | KROS | Buy Now | Keros Therapeutics | $11.42 | 425.39% | Tiago Fauth42% | → $60 | Initiates | → Overweight | Get Alert |
12/08/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.68 | 81.45% | Tiago Fauth42% | → $72 | Initiates | → Overweight | Get Alert |
12/08/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $258.00 | -33.72% | Tiago Fauth42% | → $171 | Initiates | → Equal-Weight | Get Alert |
08/11/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.36 | 4459.16% | Tiago Fauth42% | $63 → $62 | Maintains | Outperform | Get Alert |
06/14/2023 | ASND | Buy Now | Ascendis Pharma | $166.05 | -46.4% | Tiago Fauth42% | → $89 | Assumes | → Neutral | Get Alert |
06/14/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.68 | 141.94% | Tiago Fauth42% | → $96 | Assumes | → Outperform | Get Alert |
06/14/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.43 | 230.52% | Tiago Fauth42% | → $51 | Assumes | → Outperform | Get Alert |
06/14/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.36 | 4532.69% | Tiago Fauth42% | → $63 | Assumes | → Outperform | Get Alert |
06/14/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 68.26% | Tiago Fauth42% | → $120 | Assumes | → Outperform | Get Alert |
05/26/2023 | ME | Buy Now | 23andMe Holding | $1.87 | 220.86% | Tiago Fauth42% | → $120 | Reiterates | Outperform → Outperform | Get Alert |
05/23/2023 | IMVT | Buy Now | Immunovant | $18.12 | -77.92% | Tiago Fauth42% | → $4 | Reiterates | → Underperform | Get Alert |
05/23/2023 | VECT | Buy Now | VectivBio Holding | — | — | Tiago Fauth42% | $22 → $17 | Downgrade | Outperform → Neutral | Get Alert |
05/16/2023 | ABSI | Buy Now | Absci | $2.96 | 372.97% | Tiago Fauth42% | → $14 | Reiterates | Outperform → Outperform | Get Alert |
05/16/2023 | SPRB | Buy Now | Spruce Biosciences | $0.32 | 1141.46% | Tiago Fauth42% | → $4 | Reiterates | Outperform → Outperform | Get Alert |
05/11/2023 | KURA | Buy Now | Kura Oncology | $7.27 | 257.63% | Tiago Fauth42% | → $26 | Reiterates | Outperform → Outperform | Get Alert |
05/10/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.43 | 230.52% | Tiago Fauth42% | → $51 | Reiterates | → Outperform | Get Alert |
05/05/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.68 | 141.94% | Tiago Fauth42% | → $96 | Reiterates | → Outperform | Get Alert |
05/05/2023 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 1061.83% | Tiago Fauth42% | $34 → $28 | Maintains | Outperform | Get Alert |
05/05/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 223.35% | Tiago Fauth42% | $70 → $81 | Maintains | Neutral | Get Alert |
04/28/2023 | ASND | Buy Now | Ascendis Pharma | $166.05 | -46.4% | Tiago Fauth42% | $82 → $89 | Maintains | Neutral | Get Alert |
04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 68.26% | Tiago Fauth42% | $122 → $120 | Maintains | Outperform | Get Alert |
04/18/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Tiago Fauth42% | $139 → $200 | Downgrade | Outperform → Neutral | Get Alert |
04/03/2023 | ASND | Buy Now | Ascendis Pharma | $166.05 | — | Tiago Fauth42% | — | Downgrade | Outperform → Neutral | Get Alert |
04/03/2023 | HGEN | Buy Now | Humanigen | — | — | Tiago Fauth42% | → $0.5 | Reiterates | → Underperform | Get Alert |
03/24/2023 | BCAB | Buy Now | BioAtla | $0.36 | 2115.45% | Tiago Fauth42% | → $8 | Reiterates | → Neutral | Get Alert |
03/24/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.36 | 4532.69% | Tiago Fauth42% | → $63 | Reiterates | → Outperform | Get Alert |
03/23/2023 | PYXS | Buy Now | Pyxis Oncology | $1.05 | 1233.33% | Tiago Fauth42% | → $14 | Reiterates | → Outperform | Get Alert |
03/17/2023 | SPRB | Buy Now | Spruce Biosciences | $0.32 | 1141.46% | Tiago Fauth42% | → $4 | Reiterates | → Outperform | Get Alert |
03/10/2023 | ALXO | Buy Now | ALX Oncology Holdings | $0.75 | 4427.9% | Tiago Fauth42% | $38 → $34 | Maintains | Outperform | Get Alert |
03/10/2023 | GLTO | Buy Now | Galecto | $4.37 | 37.21% | Tiago Fauth42% | → $150 | Reiterates | → Outperform | Get Alert |
03/01/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Tiago Fauth42% | $142 → $139 | Maintains | Outperform | Get Alert |
02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 78.07% | Tiago Fauth42% | $110 → $127 | Maintains | Outperform | Get Alert |
02/22/2023 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 1310.79% | Tiago Fauth42% | → $34 | Reiterates | → Outperform | Get Alert |
02/17/2023 | ASND | Buy Now | Ascendis Pharma | $166.05 | -21.71% | Tiago Fauth42% | → $130 | Reiterates | → Outperform | Get Alert |
02/17/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.68 | 141.94% | Tiago Fauth42% | → $96 | Reiterates | → Outperform | Get Alert |
01/26/2023 | EXEL | Buy Now | Exelixis | $37.05 | -21.73% | Tiago Fauth42% | → $29 | Initiates | → Outperform | Get Alert |
12/16/2022 | VRDN | Buy Now | Viridian Therapeutics | $15.43 | 230.52% | Tiago Fauth42% | → $51 | Initiates | → Outperform | Get Alert |
12/16/2022 | OABI | Buy Now | OmniAb | $2.66 | 388.72% | Tiago Fauth42% | → $13 | Initiates | → Outperform | Get Alert |
12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Tiago Fauth42% | $59 → $142 | Maintains | Outperform | Get Alert |
11/18/2022 | EDIT | Buy Now | Editas Medicine | $1.40 | 828.7% | Tiago Fauth42% | $25 → $13 | Downgrade | Outperform → Neutral | Get Alert |
11/08/2022 | ME | Buy Now | 23andMe Holding | $1.87 | 220.86% | Tiago Fauth42% | $140 → $120 | Maintains | Outperform | Get Alert |
11/08/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 71.66% | Tiago Fauth42% | $45 → $43 | Maintains | Neutral | Get Alert |
11/04/2022 | BCAB | Buy Now | BioAtla | $0.36 | 2115.45% | Tiago Fauth42% | $4 → $8 | Maintains | Neutral | Get Alert |
11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.68 | 141.94% | Tiago Fauth42% | $105 → $96 | Maintains | Outperform | Get Alert |
11/03/2022 | ASND | Buy Now | Ascendis Pharma | $166.05 | -21.71% | Tiago Fauth42% | $123 → $130 | Maintains | Outperform | Get Alert |
10/27/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 54.23% | Tiago Fauth42% | $111 → $110 | Maintains | Outperform | Get Alert |
09/02/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Tiago Fauth42% | → $20 | Downgrade | Outperform → Neutral | Get Alert |
08/16/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.36 | 4532.69% | Tiago Fauth42% | $53 → $63 | Maintains | Outperform | Get Alert |
08/12/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Tiago Fauth42% | $52 → $59 | Maintains | Outperform | Get Alert |
08/12/2022 | ABSI | Buy Now | Absci | $2.96 | 372.97% | Tiago Fauth42% | $28 → $14 | Maintains | Outperform | Get Alert |
08/10/2022 | BCAB | Buy Now | BioAtla | $0.36 | 1007.73% | Tiago Fauth42% | $5 → $4 | Maintains | Neutral | Get Alert |
08/10/2022 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 1310.79% | Tiago Fauth42% | $40 → $34 | Maintains | Outperform | Get Alert |
08/09/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 107.58% | Tiago Fauth42% | $49 → $52 | Maintains | Neutral | Get Alert |
08/09/2022 | ALXO | Buy Now | ALX Oncology Holdings | $0.75 | 4960.59% | Tiago Fauth42% | $43 → $38 | Maintains | Outperform | Get Alert |
07/13/2022 | KURA | Buy Now | Kura Oncology | $7.27 | 298.9% | Tiago Fauth42% | $27 → $29 | Maintains | Outperform | Get Alert |
06/06/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 48.63% | Tiago Fauth42% | $105 → $106 | Maintains | Outperform | Get Alert |
05/27/2022 | ME | Buy Now | 23andMe Holding | $1.87 | 274.33% | Tiago Fauth42% | $220 → $140 | Maintains | Outperform | Get Alert |
05/24/2022 | UTHR | Buy Now | United Therapeutics | $318.86 | -22.54% | Tiago Fauth42% | $219 → $247 | Maintains | Outperform | Get Alert |
05/13/2022 | IFRX | Buy Now | InflaRx | $1.30 | 53.98% | Tiago Fauth42% | $2.5 → $2 | Maintains | Underperform | Get Alert |
05/12/2022 | ASND | Buy Now | Ascendis Pharma | $166.05 | -25.93% | Tiago Fauth42% | $194 → $123 | Maintains | Outperform | Get Alert |
05/09/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.36 | 3797.35% | Tiago Fauth42% | → $53 | Initiates | → Outperform | Get Alert |
05/05/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 75.65% | Tiago Fauth42% | $40 → $44 | Maintains | Neutral | Get Alert |
05/05/2022 | BCAB | Buy Now | BioAtla | $0.36 | 1284.66% | Tiago Fauth42% | $35 → $5 | Downgrade | Outperform → Neutral | Get Alert |
03/23/2022 | ABSI | Buy Now | Absci | $2.96 | 845.95% | Tiago Fauth42% | $29 → $28 | Maintains | Outperform | Get Alert |
03/14/2022 | ASND | Buy Now | Ascendis Pharma | $166.05 | 16.83% | Tiago Fauth42% | $188 → $194 | Maintains | Outperform | Get Alert |
03/10/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Tiago Fauth42% | $50 → $52 | Maintains | Outperform | Get Alert |
03/03/2022 | ASND | Buy Now | Ascendis Pharma | $166.05 | 13.22% | Tiago Fauth42% | $196 → $188 | Maintains | Outperform | Get Alert |
02/25/2022 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 1559.75% | Tiago Fauth42% | $39 → $40 | Maintains | Outperform | Get Alert |
02/25/2022 | KURA | Buy Now | Kura Oncology | $7.27 | 271.39% | Tiago Fauth42% | $25 → $27 | Maintains | Outperform | Get Alert |
02/11/2022 | ME | Buy Now | 23andMe Holding | $1.87 | 488.24% | Tiago Fauth42% | $280 → $220 | Maintains | Outperform | Get Alert |
12/20/2021 | ARGX | Buy Now | argenx | $619.97 | -45.16% | Tiago Fauth42% | $297 → $340 | Maintains | Neutral | Get Alert |
11/26/2021 | KURA | Buy Now | Kura Oncology | $7.27 | 188.86% | Tiago Fauth42% | $40 → $21 | Maintains | Outperform | Get Alert |
11/22/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 47.22% | Tiago Fauth42% | $100 → $105 | Maintains | Outperform | Get Alert |
11/16/2021 | SPRB | Buy Now | Spruce Biosciences | $0.32 | 1762.2% | Tiago Fauth42% | $26 → $6 | Maintains | Outperform | Get Alert |
11/11/2021 | ME | Buy Now | 23andMe Holding | $1.87 | 648.66% | Tiago Fauth42% | $260 → $280 | Maintains | Outperform | Get Alert |
11/11/2021 | ASND | Buy Now | Ascendis Pharma | $166.05 | 7.8% | Tiago Fauth42% | $185 → $179 | Maintains | Outperform | Get Alert |
11/02/2021 | PYXS | Buy Now | Pyxis Oncology | $1.05 | 1709.52% | Tiago Fauth42% | → $19 | Initiates | → Outperform | Get Alert |
10/28/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | 40.21% | Tiago Fauth42% | $102 → $100 | Maintains | Outperform | Get Alert |
09/10/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 51.7% | Tiago Fauth42% | $50 → $38 | Maintains | Neutral | Get Alert |
09/10/2021 | ISEE | Buy Now | IVERIC bio | — | — | Tiago Fauth42% | $15 → $18 | Maintains | Outperform | Get Alert |
08/26/2021 | ASND | Buy Now | Ascendis Pharma | $166.05 | 11.41% | Tiago Fauth42% | $178 → $185 | Maintains | Outperform | Get Alert |
08/17/2021 | ME | Buy Now | 23andMe Holding | $1.87 | 595.19% | Tiago Fauth42% | → $260 | Initiates | → Outperform | Get Alert |
08/16/2021 | ABSI | Buy Now | Absci | $2.96 | 1251.35% | Tiago Fauth42% | → $40 | Initiates | → Outperform | Get Alert |
08/13/2021 | HGEN | Buy Now | Humanigen | — | — | Tiago Fauth42% | $25 → $24 | Maintains | Outperform | Get Alert |
08/13/2021 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 1933.2% | Tiago Fauth42% | $51 → $49 | Maintains | Outperform | Get Alert |
08/10/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 99.6% | Tiago Fauth42% | $44 → $50 | Maintains | Neutral | Get Alert |
08/06/2021 | GLTO | Buy Now | Galecto | $4.37 | 60.08% | Tiago Fauth42% | $300 → $175 | Maintains | Outperform | Get Alert |
08/06/2021 | KURA | Buy Now | Kura Oncology | $7.27 | 450.21% | Tiago Fauth42% | $42 → $40 | Maintains | Outperform | Get Alert |
08/06/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Tiago Fauth42% | $102 → $98 | Maintains | Outperform | Get Alert |
08/06/2021 | IFRX | Buy Now | InflaRx | $1.30 | 92.47% | Tiago Fauth42% | $2.8 → $2.5 | Maintains | Underperform | Get Alert |
06/11/2021 | HGEN | Buy Now | Humanigen | — | — | Tiago Fauth42% | → $28 | Initiates | → Outperform | Get Alert |
06/02/2021 | IMVT | Buy Now | Immunovant | $18.12 | -33.77% | Tiago Fauth42% | $26 → $12 | Maintains | Neutral | Get Alert |
05/28/2021 | ASND | Buy Now | Ascendis Pharma | $166.05 | 7.2% | Tiago Fauth42% | $176 → $178 | Maintains | Outperform | Get Alert |
05/14/2021 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 2016.18% | Tiago Fauth42% | $53 → $51 | Maintains | Outperform | Get Alert |
05/13/2021 | IFRX | Buy Now | InflaRx | $1.30 | 115.57% | Tiago Fauth42% | $3.5 → $2.8 | Maintains | Underperform | Get Alert |
05/04/2021 | VECT | Buy Now | VectivBio Holding | — | — | Tiago Fauth42% | → $24 | Initiates | → Outperform | Get Alert |
04/29/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 55.69% | Tiago Fauth42% | $37 → $39 | Maintains | Neutral | Get Alert |
04/28/2021 | AMGN | Buy Now | Amgen | $315.75 | -17.97% | Tiago Fauth42% | $265 → $259 | Maintains | Outperform | Get Alert |
03/23/2021 | SPRB | Buy Now | Spruce Biosciences | $0.32 | 7969.52% | Tiago Fauth42% | $28 → $26 | Maintains | Outperform | Get Alert |
03/22/2021 | EDIT | Buy Now | Editas Medicine | $1.40 | 4043.45% | Tiago Fauth42% | → $58 | Initiates | → Outperform | Get Alert |
03/11/2021 | ASND | Buy Now | Ascendis Pharma | $166.05 | 5.99% | Tiago Fauth42% | $178 → $176 | Maintains | Outperform | Get Alert |
02/26/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 47.7% | Tiago Fauth42% | $35 → $37 | Maintains | Neutral | Get Alert |
02/17/2021 | IMVT | Buy Now | Immunovant | $18.12 | 43.49% | Tiago Fauth42% | $31 → $26 | Maintains | Neutral | Get Alert |
01/29/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 39.72% | Tiago Fauth42% | $31 → $35 | Maintains | Neutral | Get Alert |
01/11/2021 | BCAB | Buy Now | BioAtla | $0.36 | 13469.65% | Tiago Fauth42% | → $49 | Initiates | → Outperform | Get Alert |
01/05/2021 | ABCL | Buy Now | AbCellera Biologics | $2.41 | — | Tiago Fauth42% | — | Initiates | → Outperform | Get Alert |
12/08/2020 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Tiago Fauth42% | $64 → $68 | Maintains | Outperform | Get Alert |
11/12/2020 | ASND | Buy Now | Ascendis Pharma | $166.05 | 7.2% | Tiago Fauth42% | $158 → $178 | Maintains | Outperform | Get Alert |
11/10/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Tiago Fauth42% | $60 → $42 | Maintains | Neutral | Get Alert |
11/03/2020 | SPRB | Buy Now | Spruce Biosciences | $0.32 | 8590.25% | Tiago Fauth42% | → $28 | Initiates | → Outperform | Get Alert |
10/02/2020 | IMVT | Buy Now | Immunovant | $18.12 | 170.42% | Tiago Fauth42% | → $49 | Initiates | → Outperform | Get Alert |
08/28/2020 | ASND | Buy Now | Ascendis Pharma | $166.05 | -4.85% | Tiago Fauth42% | $154 → $158 | Maintains | Outperform | Get Alert |
08/13/2020 | ISEE | Buy Now | IVERIC bio | — | — | Tiago Fauth42% | → $13 | Initiates | → Outperform | Get Alert |
07/14/2020 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Tiago Fauth42% | → $64 | Initiates | → Outperform | Get Alert |
06/30/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Tiago Fauth42% | $137 → $59 | Downgrade | Outperform → Neutral | Get Alert |
05/21/2020 | ARGX | Buy Now | argenx | $619.97 | -74.19% | Tiago Fauth42% | $150 → $160 | Maintains | Neutral | Get Alert |
05/20/2020 | ASND | Buy Now | Ascendis Pharma | $166.05 | -7.26% | Tiago Fauth42% | $149 → $154 | Maintains | Outperform | Get Alert |
04/20/2020 | ASND | Buy Now | Ascendis Pharma | $166.05 | -10.27% | Tiago Fauth42% | $139 → $149 | Maintains | Outperform | Get Alert |
03/02/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 35.73% | Tiago Fauth42% | $36 → $34 | Maintains | Neutral | Get Alert |
12/17/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Tiago Fauth42% | $87 → $141 | Maintains | Outperform | Get Alert |
11/05/2019 | APLS | Buy Now | Apellis Pharmaceuticals | $25.05 | 31.74% | Tiago Fauth42% | → $33 | Initiates | → Neutral | Get Alert |
11/05/2019 | ARGX | Buy Now | argenx | $619.97 | -77.9% | Tiago Fauth42% | → $137 | Initiates | → Neutral | Get Alert |
01/31/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Tiago Fauth42% | → $167 | Initiates | → Outperform | Get Alert |
12/10/2018 | IFRX | Buy Now | InflaRx | $1.30 | 3518.45% | Tiago Fauth42% | → $47 | Initiates | → Outperform | Get Alert |
03/30/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Tiago Fauth42% | → $200 | Initiates | → Outperform | Get Alert |